Corning launches the Elplasia 12K flask, for drug screening and other applications
Newest 3D cell culture solution from Corning enables production of ~12,000 spheroids of uniform size and geometry
Newest 3D cell culture solution from Corning enables production of ~12,000 spheroids of uniform size and geometry
The Corning Matribot bioprinter features a temperature-controlled printhead, enabling an ideal system for Matrigel matrix dispensing and printing
Corning 3D solutions, including the company’s new Matribot bioprinter, support life science innovation in areas including drug screening and precision medicine
Corning expands cell culture portfolio with 3D liver models that better recapitulate in vivo behavior and deliver a more physiologically relevant model for improved drug safety and efficacy screening
The new solutions support evolving industry needs such as COVID-19 response, disease models, and drug discovery
The platform aims to deliver rapid and automated processing of human blood and blood products to obtain purified populations of immune cells
The pre-coated Matrigel matrix-3D plates aim to streamline workflows and deliver a more consistent and convenient solution for high-throughput environments
Corning® Elplasia® plates and Matrigel® matrix for organoid culture enables development of more predictive models for cancer and other critical diseases
An automated system designed to increase efficiency in cell therapy research
Corning Elplasia plates and Matrigel matrix for organoid culture are designed to help develop more predictive models for cancer and other critical diseases
Automated system designed to increase efficiency in cell therapy research
Hilary Sherman and Hannah J. Gitschier M.S. Corning Incorporated, Life Sciences Kennebunk, ME USA
Discover 3D cell culture, spheroids, organoids, tissue models, advanced 3D technologies and more at this year's AACR
High-throughput spheroid microplate benefits cancer research and drug screening
Collaborations result in development of Corning Valor™ Glass and drive significant U.S. investment and job creation
Corning® TransportoCells™ ABC Transporter Vesicles and Corning Supersomes™ Ultra Human Aldehyde Oxidase (AO) Enzyme are now commercially available
Corning Life Sciences showcases diverse and growing portfolio
Highlights include tools for 3D cell culture
Optimize Assay Performance and Streamline High Throughput Screening
Corning Life Sciences vice president and general manager to showcase growing portfolio
Corning to become global channel distributor for select BioCision products
Single-use, highly consistent alternative to primary human hepatocytes